» Articles » PMID: 14985375

Mutations in SCN9A, Encoding a Sodium Channel Alpha Subunit, in Patients with Primary Erythermalgia

Overview
Journal J Med Genet
Specialty Genetics
Date 2004 Feb 27
PMID 14985375
Citations 256
Authors
Affiliations
Soon will be listed here.
Abstract

Primary erythermalgia is a rare autosomal dominant disease characterised by intermittent burning pain with redness and heat in the extremities. A previous study established the linkage of primary erythermalgia to a 7.94 cM interval on chromosome 2q, but the causative gene was not identified. We performed linkage analysis in a Chinese family with primary erythermalgia, and screened the mutations in the two candidate genes, SCN9A and GCA, in the family and a sporadic patient. Linkage analysis yielded a maximum lod score of 2.11 for both markers D2S2370 and D2S2330. Based on critical recombination events in two patients in the family, we further limited the genetic region to 5.98 cM between D2S2370 and D2S2345. We then identified two missense mutations in SCN9A in the family (T2573A) and the sporadic patient (T2543C). Our data suggest that mutations in SCN9A cause primary erythermalgia. SCN9A, encoding a voltage-gated sodium channel alpha subunit predominantly expressed in sensory and sympathetic neurones, may play an important role in nociception and vasomotor regulation.

Citing Articles

Primary Erythromelalgia: Historical Perspective and Current Update.

Eaton A, Mayrovitz H Cureus. 2025; 17(2):e78576.

PMID: 40062126 PMC: 11890538. DOI: 10.7759/cureus.78576.


Small-Fiber Neuropathy: An Etiology-Oriented Review.

Furia A, Liguori R, Donadio V Brain Sci. 2025; 15(2).

PMID: 40002491 PMC: 11853085. DOI: 10.3390/brainsci15020158.


Discordance between preclinical and clinical testing of Na V 1.7-selective inhibitors for pain.

Yang J, Xie Y, Smith R, Ratte S, Prescott S Pain. 2025; 166(3):481-501.

PMID: 39928833 PMC: 11808711. DOI: 10.1097/j.pain.0000000000003425.


Voltage-gated sodium channels in excitable cells as drug targets.

Alsaloum M, Dib-Hajj S, Page D, Ruben P, Krainer A, Waxman S Nat Rev Drug Discov. 2025; .

PMID: 39901031 DOI: 10.1038/s41573-024-01108-x.


US drug agency approves potent painkiller - the first non-opioid in decades.

Dolgin E Nature. 2025; 638(8050):304-305.

PMID: 39885357 DOI: 10.1038/d41586-025-00274-1.